Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KITE study
2023-506642-23-00Phase 2Withdrawn
- Sponsor
- Molecure
- Start
- Jan 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 8
01
Overview
Phase 2, randomised, double-blind trial in pulmonary sarcoidosis comparing OATD-01 with Placebo (2 arms). Primary endpoint: Response to treatment. Planned start Jan 2024; status: withdrawn.
02
Drugs
OATD-01
03
Conditions
pulmonary sarcoidosis
Beyond the preview
Go deeper on 2023-506642-23-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-506642-23-00.